TIDES US Post-event Report:Emerging RNA and Oligonucleotide Technologies and Applications
Boston, MAMay 2024
TIDES Europe 2023 witnessed the largest turnout in the history of the event, welcoming more than 600 attendees from across the globe. The conference took place 30 October – 1 November in Amsterdam, NL and featured new data & case studies from...
Introduction
Editing the Genome with Cas9 mRNA
New Ligation Approach: Technology for High Quality Manufacturing of Over 150 mer RNA
Expanding the mRNA Ecosystem
Optimizing Production of Chemically Modified sgRNA with High Quality
Enzymatic Synthesis of RNA with Chemical Modifications
Programmable Molecular Technologies for Genome Editing and Cell Control
Two Enzymatic Approaches for Large-scale siRNA Synthesis
A Scalable Versatile System for mRNA-LNP Formulation Based on Impingement Jets Mixing Technology - From R&D to Commercial Drug Substance Production
Non-viral RNA Delivery with Biodegradable Lipids
mRNA Characterization, from 5’ Cap to Poly (A): What IP-RP-MS Can Tell You
Pioneering a Versatile LNP Production Process for mRNA Vaccines, Therapeutics, and Gene Editing - Unveiling the Proof of Concept
Our Progress in Taking xRNA Manufacturing Digital
A Comprehensive Analysis of the mRNA-lipid Nanoparticle (mRNA-LNP) by Capillary Electrophoresis (CE) and LC-MS
Process Development of sgRNA in CRISPR/CAS Therapeutics
Characterization and Mitigation of Impurities in Oligonucleotides Containing Methansulfonylphosphoramidate Linkages
Exclusive Exhibitor Highlights